Denis Guilloteau

10.0k total citations
234 papers, 7.6k citations indexed

About

Denis Guilloteau is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Denis Guilloteau has authored 234 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Cellular and Molecular Neuroscience, 94 papers in Molecular Biology and 52 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Denis Guilloteau's work include Neuroscience and Neuropharmacology Research (68 papers), Neurotransmitter Receptor Influence on Behavior (51 papers) and Medical Imaging Techniques and Applications (37 papers). Denis Guilloteau is often cited by papers focused on Neuroscience and Neuropharmacology Research (68 papers), Neurotransmitter Receptor Influence on Behavior (51 papers) and Medical Imaging Techniques and Applications (37 papers). Denis Guilloteau collaborates with scholars based in France, Sweden and Australia. Denis Guilloteau's co-authors include Sylvie Chalon, Jean‐Claude Besnard, Georges Durand, Sylvie Vancassel, Patrick Emond, Luc Zimmer, Sylvie Bodard, Lucette Garreau, Christer Halldin and Nicolas Arlicot and has published in prestigious journals such as Journal of Neuroscience, PLoS ONE and NeuroImage.

In The Last Decade

Denis Guilloteau

231 papers receiving 7.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Denis Guilloteau France 43 2.1k 1.9k 1.6k 1.5k 1.4k 234 7.6k
Sylvie Chalon France 43 2.3k 1.1× 2.0k 1.0× 1.4k 0.9× 1.5k 1.0× 1.9k 1.3× 208 8.0k
Dorit Ben‐Shachar Israel 47 2.0k 0.9× 2.6k 1.4× 2.0k 1.2× 1.1k 0.7× 808 0.6× 102 7.5k
Nicole Baumann France 45 1.9k 0.9× 3.2k 1.7× 1.0k 0.6× 1.4k 1.0× 541 0.4× 239 8.4k
Geoffrey A. Kerchner United States 32 2.7k 1.3× 2.0k 1.0× 768 0.5× 1.8k 1.2× 483 0.3× 74 6.0k
Jay W. Pettegrew United States 46 1.3k 0.6× 2.6k 1.3× 625 0.4× 2.4k 1.6× 346 0.2× 140 7.1k
Edward G. Stopa United States 53 2.2k 1.0× 2.4k 1.2× 1.5k 0.9× 2.8k 1.9× 320 0.2× 128 9.4k
Margaret E. Rice United States 55 4.6k 2.2× 3.2k 1.6× 1.4k 0.8× 1.1k 0.7× 795 0.5× 123 9.3k
William H. Oldendorf United States 42 2.3k 1.1× 2.1k 1.1× 901 0.6× 1.6k 1.0× 424 0.3× 142 8.1k
Paul A. Adlard Australia 50 1.6k 0.7× 2.6k 1.3× 1.3k 0.8× 3.9k 2.6× 2.7k 1.9× 155 9.8k
Manfred Gerlach Germany 44 2.0k 1.0× 1.7k 0.9× 2.6k 1.6× 1.1k 0.7× 489 0.3× 174 6.7k

Countries citing papers authored by Denis Guilloteau

Since Specialization
Citations

This map shows the geographic impact of Denis Guilloteau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denis Guilloteau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denis Guilloteau more than expected).

Fields of papers citing papers by Denis Guilloteau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Denis Guilloteau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denis Guilloteau. The network helps show where Denis Guilloteau may publish in the future.

Co-authorship network of co-authors of Denis Guilloteau

This figure shows the co-authorship network connecting the top 25 collaborators of Denis Guilloteau. A scholar is included among the top collaborators of Denis Guilloteau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Denis Guilloteau. Denis Guilloteau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guilloteau, Denis, et al.. (2019). Development of a Fast and Facile Analytical Approach to Quantify Radiometabolites in Human Plasma Samples Using Ultra High Performance Liquid Chromatography. American Journal of Analytical Chemistry. 10(5). 185–201. 2 indexed citations
2.
Sérrière, Sophie, Clovis Tauber, Johnny Vercouillie, et al.. (2013). In vivo PET quantification of the dopamine transporter in rat brain with [18F]LBT-999. Nuclear Medicine and Biology. 41(1). 106–113. 13 indexed citations
3.
Mavel, Sylvie, et al.. (2009). Synthesis and in vitro evaluation of fluorinated diphenyloxide derivatives and sulfur analogs as serotonin transporter ligands. Bioorganic & Medicinal Chemistry. 18(1). 236–241. 11 indexed citations
4.
Emond, Patrick, Denis Guilloteau, & Sylvie Chalon. (2008). PE2I: A Radiopharmaceutical forIn vivoExploration of the Dopamine Transporter. CNS Neuroscience & Therapeutics. 14(1). 47–64. 38 indexed citations
5.
Chitneni, Satish K., Lucette Garreau, Bernard Cleynhens, et al.. (2007). Improved synthesis and metabolic stability analysis of the dopamine transporter ligand [18F]FECT. Nuclear Medicine and Biology. 35(1). 75–82. 15 indexed citations
6.
Bertrand, Philippe B., et al.. (2007). Evaluation of a Solid Bolus Suitable for Esophageal Scintigraphy. Dysphagia. 22(4). 281–289. 3 indexed citations
7.
Saba, Wadad, Héric Valette, Sylvie Chalon, et al.. (2006). [18F]LBT-999, a new radioligand to study the dopamine transporter with PET: Characterization in baboons. NeuroImage. 31. T132–T132. 2 indexed citations
8.
Cantagrel, S., Sarah Ducrocq, Sylvie Bodard, et al.. (2003). Hypoxic preconditioning reduces apoptosis in a rat model of immature brain hypoxia-ischaemia. Neuroscience Letters. 347(2). 106–110. 38 indexed citations
9.
Fernagut, Pierre‐Olivier, Sylvie Chalon, Elsa Diguet, et al.. (2003). Motor behaviour deficits and their histopathological and functional correlates in the nigrostriatal system of dopamine transporter knockout mice. Neuroscience. 116(4). 1123–1130. 67 indexed citations
10.
Chalon, Sylvie, Anne Aubert‐Pouëssel, Marie‐Claire Venier‐Julienne, et al.. (2002). Protection of dopaminergic nigrostriatal afferents by GDNF delivered by microspheres in a rodent model of Parkinson's disease. Synapse. 44(3). 124–131. 31 indexed citations
11.
Zimmer, Luc, Sylvie Vancassel, S. Cantagrel, et al.. (2002). The dopamine mesocorticolimbic pathway is affected by deficiency in n−3 polyunsaturated fatty acids. American Journal of Clinical Nutrition. 75(4). 662–667. 172 indexed citations
12.
Emond, Patrick, Johnny Vercouillie, Robert B. Innis, et al.. (2002). Substituted Diphenyl Sulfides as Selective Serotonin Transporter Ligands:  Synthesis and In Vitro Evaluation. Journal of Medicinal Chemistry. 45(6). 1253–1258. 32 indexed citations
13.
Vancassel, Sylvie, G. Durand, Catherine Barthélémy, et al.. (2001). Plasma fatty acid levels in autistic children. Prostaglandins Leukotrienes and Essential Fatty Acids. 65(1). 1–7. 193 indexed citations
14.
Zimmer, Luc, Serge Delpal, Denis Guilloteau, et al.. (2000). Chronic n-3 polyunsaturated fatty acid deficiency alters dopamine vesicle density in the rat frontal cortex. Neuroscience Letters. 284(1-2). 25–28. 136 indexed citations
15.
Bergström, Kim, Marko Huotari, Anu J. Airaksinen, et al.. (1999). L-[2-radio iodo] tyrosine, a new potential protein synthesis and tumour tracer for spect: Radiosynthesis and biodistribution in rodent.. European Journal of Nuclear Medicine and Molecular Imaging. 26. 971–971. 2 indexed citations
16.
Yu, Meixiang, et al.. (1999). Synthesis of [p-methyl-11C]RTI-32: A new tool for the in vivo evaluation of the metabolism of phenyltropane dopamine reuptake compounds. Journal of Labelled Compounds and Radiopharmaceuticals. 42. 4 indexed citations
17.
Baulieu, J.-L., M.J. Santiago Ribeiro, F. Tranquart, et al.. (1999). Effects of the method of drawing regions of interest on the differential diagnosis of extrapyramidal syndromes using 123I-iodolisuride SPET. Nuclear Medicine Communications. 20(1). 77–84. 5 indexed citations
18.
Léna, Isabelle, Sylvie Chalon, Jean‐Louis Baulieu, et al.. (1995). Iododerivative of pargyline: A potential tracer for the exploration of monoamine oxidase sites by SPECT. Nuclear Medicine and Biology. 22(6). 727–736. 5 indexed citations
19.
Chalon, Sylvie, et al.. (1994). Chronic Dietary α-Linolenic Acid Deficiency Alters Dopaminergic and Serotoninergic Neurotransmission in Rats , ,. Journal of Nutrition. 124(12). 2466–2476. 1 indexed citations
20.
Baulieu, Jean‐Louis, et al.. (1984). [Imaging medullary cancer of the thyroid].. PubMed. 71(3). 182–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sylvie Chalon Breakdown of academic impact, for papers by Dorit Ben‐Shachar Breakdown of academic impact, for papers by Nicole Baumann Breakdown of academic impact, for papers by Geoffrey A. Kerchner Breakdown of academic impact, for papers by Jay W. Pettegrew Breakdown of academic impact, for papers by Edward G. Stopa Breakdown of academic impact, for papers by Margaret E. Rice Breakdown of academic impact, for papers by William H. Oldendorf Breakdown of academic impact, for papers by Paul A. Adlard Breakdown of academic impact, for papers by Manfred Gerlach
Rankless by CCL
2026